http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-034516-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6572ff5df928fd17340eb2a8cb6d8502
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-08
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D205-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C237-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D205-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4453
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-403
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-397
filingDate 2002-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1fac79b63762202579c2468110cef72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_199a26f57c2a8055bc43b63a152e6672
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20cfcf885fc60671f23f345ff1ebcdd8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_044fcf574eb66d28bc885ee62f1ae300
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ef9083525b73d357c20adf5935d408b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eab92cc570bd9fa40e229186e0795ceb
publicationDate 2004-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-034516-A1
titleOfInvention ALFA AMINO-RANGE-HYDROXYAMID CYCLING COMPOUNDS, A PROCEDURE FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
abstract Compounds of the formula (1) wherein A represents an optionally substituted saturated carbon ring having between 4 and 8 ring members, R1 and R4 that may be identical or different, each represents a hydrogen atom or an acyl group, R2 and R3, which may be identical or different, each represent a hydrogen atom or an alkyl group, R5 and R6, which may be identical or different, each represent a hydrogen atom or an alkyl group, or R5 and R6 together, with the nitrogen atom that carries them, form a heterocycle with optionally substituted nitrogen content, stereoisomers thereof, and also, addition salts thereof with a pharmaceutically acceptable acid. Antidiabetic medications
priorityDate 2001-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297

Total number of triples: 50.